Metvix
Metvix is a medicine authorised by Swissmedic under authorisation number 56134. The authorisation holder is Galderma SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 November 2003 and the authorisation is valid without a time limit. ATC code L01XD03 places the medicine in the group Antineoplastic agents.
| Authorisation number | 56134 |
|---|---|
| Name | Metvix |
| Full name | Metvix, Crème |
| Authorisation holder | Galderma SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L01XD03 |
| First authorisation | 05 November 2003 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Metvix, Crème | B | 05 November 2003 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 2 | g | L01XD03 | 07.16.4. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Metvix authorised in Switzerland?
Yes. Metvix is authorised by Swissmedic under authorisation number 56134, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Metvix have?
Metvix is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Metvix?
The authorisation holder is Galderma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.